Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma

Cancer Immunology, Immunotherapy

Volumn 61, Issue 9, 2012, Pages 1425-1432

  Kohga, Keisuke ^a   Tatsumi, Tomohide ^a   Tsunematsu, Hinako ^a   Aono, Satoshi ^a   Shimizu, Satoshi ^a   Kodama, Takahiro ^a   Hikita, Hayato ^a   Yamamoto, Masashi ^a   Oze, Tsugiko ^a   Aketa, Hiroshi ^a   Hosui, Atsushi ^a   Miyagi, Takuya ^a   Ishida, Hisashi ^a   Hiramatsu, Naoki ^a   Kanto, Tatsuya ^a   Hayashi, Norio ^b   Takehara, Tetsuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

ADAM9; Hepatocellular carcinoma; IL 1 ; Soluble MICA

Indexed keywords

DISINTEGRIN; GELATINASE B; HLA A ANTIGEN; INTERLEUKIN 1BETA; MESSENGER RNA;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE; GENE SILENCING; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIVER CELL CARCINOMA; MALE; MICA GENE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STOMACH CANCER; TUMOR CELL DESTRUCTION; TUMOR ESCAPE; UPREGULATION; UTERINE CERVIX CANCER;

ADAM PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; HEP G2 CELLS; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERLEUKIN-1BETA; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED;

EID: 84866560750     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1208-6     Document Type: Article

References (37)

1. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-2147 (Pubitemid 26086851)
2. Napoli J, Bishop GA, McGuinness PH, Painter DM, McCaughhan GW (1996) Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759-765 (Pubitemid 26334270)
3. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR (2000) Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31:828-833 (Pubitemid 30169926)
4. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, Huber C (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274
5. Bidwell J, Keen L, Gallagher G et al (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1:3-19 (Pubitemid 129622776)
6. El-Omar EM, Carrington M, Chow WH et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402 (Pubitemid 30164342)
7. Howell WM, Calder PC, Grimble RF (2002) Gene polymorphism, inflammatory disease and cancer. Proc Nutr Soc 61:447-456
8. Wang Y, Kato N, Hoshida Y et al (2003) Interleukin-1b gene polymorphism associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37:65-71 (Pubitemid 36042146)
9. Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, Hirashima N, Sugauchi F, Ueda R, Mizokami M (2003) Impact of interleukin-1b genetic polymorphism on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infec Dis 187:1822-1825 (Pubitemid 36667895)
10. Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y (2006) Interleukin-1b gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 12:776-779 (Pubitemid 43380763)
11. Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG, Wang TC (2008) Overexpression of interleukin-1b induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14:408-419
12. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T (1999) Broad tumor-associated expression and recognition by tumor-derived cdT cells of MICA and MICB. Proc Natl Acad Sci USA 96:6879-6884 (Pubitemid 29274978)
13. Jinushi M, Takehara T, Tatsumi T et al (2003) Expression of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acids. Int J Cancer 104:354-361 (Pubitemid 36249818)
14. Ogasawara K, Lanier LL (2005) NKG2D in NK and T cellmediated immunity. J Clin Immunol 25:534-540
15. Caudert JD, Held W (2006) The role of the NKG2D receptor for tumor immunity. Semin Cancer Biol 16:333-343 (Pubitemid 44311504)
16. Groh V, Wu J, Yee C, Spies T (2002) Tumor-derived soluble MIC ligands impair expression of NKG2D and T cell activation. Nature 419:734-738 (Pubitemid 35177960)
17. Salih HR, Rammensee HG, Steinle A (2002) Downregulation of MICA on human tumors by proteolytic shedding. J Immunol 169: 4098-4102 (Pubitemid 35178177)
18. Kohga K, Takehara T, Tatsumi T et al (2008) Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver disease and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci 99:1643-1649
19. Kohga K, Takehara T, Tatsumi T, Ishida H, Miyagi T, Hosui A, Hayashi N (2010) Sorafenib inhibits the shedding of MICA on hepatocellular carcinoma cell by downregulating ADAM9. Hepatology 51:1264-1273
20. Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR (2006) Soluble MICA in malignant disease. Int J Cancer 118: 684-687
21. Doherty DG, O'Farrelly C (2000) Innate and adaptive lymphoid cells in human liver. Immunol Rev 174:5-20 (Pubitemid 30201375)
22. Mehal WZ, Azzaroli F, Crispe IN (2001) Immunology of the healthy liver: old questions and new insights. Gatsroenterology 120:250-260 (Pubitemid 32061889)
23. Guerra N, Tan YX, Joncker NT et al (2008) NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28:571-580
24. Kohga K, Takehara T, Tatsumi T, Miyagi T, Ishida H, Ohkawa K, Kanto T, Hiramatsu N, Hayashi N (2009) Anti-cancer chemotherapy inhibits MICA ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res 69:8050-8057
25. Oyanagi Y, Takahashi T, Matsui S, Takahashi S, Boku S, Takahashi K, Furukawa K, Arai F, Asakura H (1999) Enhanced expression of interleukin-6 in chronic hepatitis C. Liver 19:464-472 (Pubitemid 30019059)
26. Lapinski TW (2001) The levels of IL-1b, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients. Arch Immunol Ther Exp 49:311-316
27. Bortolami M, Kotsafti A, Cardin R, Farinati F (2008) Fas/FasL system, IL-1b expression and apoptosis in chronic HBV and HCV liver disease. J Viral Hepat 15:515-522 (Pubitemid 351798989)
28. Migita K, Abiru S, Maeda Y et al (2005) Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Human Immunol 67:27-32
29. Nakagawa H, Maeda S, Yoshida H et al (2009) Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender difference. Int J Cancer 125:2264-2269
30. Wong VW, Yu J, Cheng AS et al (2009) High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B. Int J Cancer 124:2766-2770
31. Waldhauer I, Goehlsdorf D, Gieseke F et al (2008) Tumorassociated MICA is shed by ADAM proteases. Cancer Res 68: 6368-6376
32. Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7-30 (Pubitemid 36062504)
33. Yaykasli KO, Oohashi T, Hirohata S, Hatipoglu OF, Inagawa K, Demircan K, Ninomiya Y (2009) ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes. Mol Cell Biochem 323:69-79
34. Kalinski T, Krueger S, Sel S, Wemer K, Ropke M, Roessner A (2007) ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma. Hum Pathol 38:86-94 (Pubitemid 44880204)
35. Cai L, Zhang Z, Zhou L et al (2008) Functional impairment in circulating and intrahepatic NK cell and relative mechanism in hepatocellular carcinoma patients. Clin Immunol 129:428-437
36. Hassan G, Moreno S, Massimi M, Di Biagio P, Stefanini S (1997) Interleukin-1-producing plasma cells in close contact with hepatocytes in patients with chronic active hepatitis. J Hepatol 27:6-17 (Pubitemid 27357048)
37. Gabby C, Lamacchia C, Palmer G (2010) IL-1 pathway in inflammation and human disease. Nat Rev Rheumatol 6:232-241